New aspects of Helicobacter pylori infection: Association with metabolic disturbances


Cite item

Full Text

Abstract

The review is devoted to the analysis of the literature on the possible association of Helicobacter pylori infection with type 2 diabetes mellitus, metabolic syndrome and its supposed mechanisms.

Full Text

АГ — артериальная гипертония ИМТ — индекс массы тела ИР — инсулинорезистентность ЛПВП — липопротеины высокой плотности ЛПНП — липопротеины низкой плотности МС — метаболический синдром ОС — окислительный стресс СД — сахарный диабет СД-2 — СД 2-го типа СО — слизистая оболочка ССЗ — сердечно-сосудистые заболевания ТГ — триглицериды УГК — уровень глюкозы в крови ХС — холестерин HbA1c — гликированный гемоглобин IFN-γ — интерферон-γ IL — интерлейкин TNF-α — α-фактор некроза опухоли Аннотация
×

About the authors

S V German

I P Bobrovnitsky

References

  1. Решетников О.В., Курилович С.А., Кротов С.А., Кротова В.А. Мониторинг инфекции, вызываемой Helicobacter pylori в Новосибирске. Журнал микробиологии, эпидемиологии, иммунобиологии. 2008;1:99-100.
  2. Герман С.В., Зыкова И.Е., Ермаков Н.В., Модестова А.В. Распространенность инфекции Н. pylori среди населения Москвы. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2010;2:25-30.
  3. Дедов И.И., Шестакова М.В., Викулова О.К. Государственный регистр сахарного диабета в Российской Федерации: статус 2014 г. и перспективы развития. Сахарный диабет. 2015;(18)3:5-22. [Dedov II, Chestakova MV, Vikulova OK. State Register of diabetes mellitus in the Russian Federation: status of 2014, and prospects for development. Saharny diabet. 2015;(18)3:5-22.] https://doi.org/10.14341/DM201535-22
  4. Simon L, Tornoczky J, Toth M, Jambor M, Sudar Z. The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice. Orv Hetil. 1989;130:1325-1329.
  5. Demir M, Gokturk HS, Ozturk NA,Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci. 2008;53(10):2646-2649.
  6. Hamed SA, Amine NF, Galal GM, Helal SR, Shawky OA Vascular risks and complications in diabetes mellitus. The role of Helicobacter pylori infection. J Stroke Cerebrovasc Dis. 2008;17:876-94. https://doi.org/10.1016/j
  7. Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, Aiello AE. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care. 2012;35(3):520-525. https://doi.org/10.2337/dc11-1043
  8. Zhou X, Zhang C, Wu J, Zhang G. Association between Helicobacter pylori infection and diabetes mellitus : a meta-analysis of observational studies. Diabetes Res Clin Pract. 2013;99:200-208. https://doi.org/10.1016/j.diabres.2012.11.012
  9. Bajaj S, Rekwal L, Misra SP, Misra V, Yadav RK, Srivastava A. Association of Helicobacter pylori infection with type 2 diabetes. Indian J Endocrinol Metab. 2014;18:694-699.
  10. Yang G-H, Wu J-S, YangY-C, Huang Y-H, Lu F-H, Chang C-J. Gastric Helicobacter pylori infection associated with risk of diabetes mellitus, but not prediabetes. J Gastroenterol Hepatol. 2014;29:1794-1799. https://doi.org/10.1111/jgh.12617
  11. Franceshi F, Gasbarrini A, Polyzos SA, Kountouras J. Extragastric diseases and Helicobacter pylori. Helicobacter. 2015;20(S1):40-46. https://doi.org/10.1111/hel.12256
  12. Chen Yu, Blaser MH. Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis. 2012;205(8):1195-1202. https://doi.org/10.1093/infdis/jis106
  13. Hsieh MC, Wang SS, Hsieh YT, Kuo FC, Soon MS, Wu DC. Helicobacter pylori infection associated with high HbA1c and type 2 diabetes. Eur J Clin Invest. 2013;43(9):949-956. https://doi.org/10.1111/eci.12124
  14. Yang Z, Li W, He C, Xie C, Zhu Y, Lu N-H. Potential effect of chronic Helicobacter pylori infection on glucose metabolism of Mongolian gebrils. WJG. 2015;21(44):12593-12604. https://doi.org/10.3748/wjg.v21.i44.12593
  15. Marietti M, Gasbarrini A, Saracco G, Pellicano R. Helicobacter pylori infection and diabetes mellitus:the 2013 state of art. Panminerva Med. 2013;55(3):277-281.
  16. Patel PS, Buras ED, Balasubramanyam A. The role of immune system in obesity and insulin resistance. J of Obesity. 2013;9:616193.
  17. Vafaeimanesh J, Parham M, Seyyedmajidi M, Bagherzadeh M. Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population. Sci Word J. 2014;2014:1-5. https://doi.org/10.1155/2014/391250
  18. Zhou X, Liu W, Gu M, Zhou H, Zhang G. Helicobacter pylori infection causes hepatic insulin resistance through the с-Jun/miR-203/SOCS3 signaling pathway. Gastroenterology. 2015;148(4):83. https://doi.org/10.1016/s0016-5085(15)30287-0
  19. Aydemir S, Bayaraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, Gun BD, Borazan A, Ustundag Y. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci. 2005;50:2090-2093.
  20. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and lowgrade inflammation. South Med J. 2010;103(3):190-196. https://doi.org/10.1097/smj.0b013e3181cf373f
  21. Aslan M, Horoz M, Nazligul Y, Bolukbas C, Bolukbas FF, Selek S, Celik H, Erel O. Insulin resistance in H. рylori infection and its association with oxidative stress. WJG. 2006;12(42):6865-6868.
  22. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A . Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter. 2009;14(5):496-502. https://doi.org/10.1111/j.1523-5378.2009.00705.x
  23. Eshraghian A, Hashemi SA, Jahromi AH, Eshraghian H, Masoompour SM, Davarpanah MA, Eshraghian K, Taghavi SA. Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci. 2009;54(9):1966-1970.
  24. Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter. 2011;16:79-88. https://doi.org/10.1111/j.1523-5378.2011.00822.x
  25. Gillum RF. Infection with Helicobacter pylori, coronary heart diseases, cardiovascular risk factors, and systemic inflammation:the Third National Health and Nutrition Examination Survey. J Natl Med Assoc. 2004;96:1470-1476.
  26. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IR, Sohn CI, Kim , Keum DK. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc. 2005;97(4):508-513.
  27. Algood HM, Cover TL. Helicobacter pylori persistence:an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev. 2006;19:597-613.
  28. Buzas GM. Metabolic consequences of Helicobacter pylori infection and eradication. WJG. 2014;20(18):5226-5234. https://doi.org/10.3748/wjg.v20.i18.5226
  29. He C, Yang Z, Lu N-H. Helicobacter pylori infection and diabetes:Is it a myth or fact? WJG. 2014;20(16):4607-4617. https://doi.org/10.3748/wjg.v20.i16.4607
  30. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793-1801.
  31. Fernandez-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2008;19:10-16.
  32. Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38:183-191. https://doi.org/10.1016/j.diabet.2011.11.006
  33. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
  34. Spranger J, Kroke A, Molig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes:results of the prospective population-based European Prospective Investigation into Cancer and Nutririon (EPIC)-Potsdam Study. Diabetes. 2003;52:812-817.
  35. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005;7:1040-1052.
  36. Shin MJ, Park E, Lee JH, Chung N. Relationship between insulin resistance and lipid peroxidation and antioxidant vitamins and hypercholesterolemic patients. Ann Nutr Metab. 2006;50:115-120.
  37. Henriksen EJ Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radical Biol Med. 2011;51(5):993-999. https://doi.org/10.1016/j.freeradbiomed.2010.12.005
  38. Fosslien E. Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci. 2001;31:25-67.
  39. Rahman MA, Cope MB, Sarker SA, Garvey WT, Chaudhury HS, Khaled MA. Helicobacter pylori infection and inflamma-tion:implication for the pathophysiology of diabetes and coronary heart disease in Asian Indians. J Life Sci. 2009;1:45-50.
  40. Kaneko H, Konagaya T, Kusugami K. Helicobacter pylori and gut gormones. J Gastroenterol. 2002;37(2):77-86
  41. Roper J, Francois F, Shue PL, Mourad MS, Pei Z, Olivares de Perez AZ, Perez-Perez GI, Tseng CH, Blaser MJ. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab. 2008;93:2350-2357.
  42. Polyzos SA, Kountouras J. Novel advances in the association between Helicobacter pylori infection, metabolic syndrome, and related morbidity. Helicobacter. 2015;20(6):405-409. https://doi.org/10.1111/hel.12228
  43. Franceshi F, Sepulveda AR, Gasbarrini A, et al. Cross reactivity of anti-Cag A antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation. 2002;106:430-434.
  44. Ibrahim A, Zaher T, Ghonemy TA, El-Azim SA, El-Azim MA, Ramadan A. Impact of cytotoxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes. Saud J Kidney Dis Transpl. 2010;21(4):694-700. https://doi.org/10.4314/ajnt.v3i2.58892
  45. Yanik S, Dogan ZA, Sarikaya M, Ergul B, Filik L. Helicobacter pylori eradication reduces microalbuminuria in type- 2 diabetic patients:a prospective study. Acta gastroenterol Belg. 2014;77:235-239.
  46. Zojaji H Ataei E, Sherafat SJ, Ghobakhlou M. The effect of treatment of Helicobacter pylori infection on the glycemic control in type 2 diabetes mellitus. Gastroenterol Hepatol Bed Bench. 2013; 6:36-40.
  47. Dai Y-N, Yu W-L, Zhu H-T, Ding J-X, Yu C-H, Li Y-M. Is Helicobacter pylori infection associated with glycemic control in diabetes? WJG. 2015;21(17):5407-5416. https://doi.org/10.3748/wjg.v21.i17.5407
  48. WadaY, Hamamoto Y, Kawasaki Y, Honjo S, Fujimoto K, Tatsuoka H, Matsuoka A, Ikeda H, Fujikawa J, Koshiyama H. The eradication of Helicobacter pylori does not affect glycemic control in japanese subjects with type 2 diabetes. Jpn Clin Med. 2013;3:41-43. https://doi.org/10.4137/jcm.s10828
  49. Oluyemi A, Anomneze E, Smith S, Fasanmade O. Prevalence of a marker of active Helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria. BMC Res Notes. 2012;5:284. https://doi.org/10.1186/1756-0500-5-284
  50. Malamug LR, Kamchanasom R, Samoa R, Chiu KC. The role of Helicobacter pylori in insulin sensitivity, beta cell function, and abnormal glucose tolerance. Scientifica (Cairo). 2014;2014:870185. https://doi.org/10.1155/2014/870165
  51. Sotuneh N, Hosseini SR, Shokri-Shirvani J, Bijani A, Ghadimi R. Helicobacter pylori infection and metabolic parametrs: is there association in elderly population? Int J Prev Med. 2014;5(12):1537-1542.
  52. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe Net al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol. 2008;103:3005-3010.
  53. Сhen TP, Hung HF, Сhen MК Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: a cross-sectional study. Helicobacter. 2015;20:184-191.
  54. Sharnagl H, Kist M, Grawitz AB, Koenig W, Wieland H, Marz W. Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol. 2004;93:219-220.
  55. Jia EZ, Zhao FJ, Hao B, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ, Yang ZJ, Zhang G. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis. 2009;8:59-61.
  56. Kucukazman M, Yavuz B, Sacikara M, Asilturk Z, Ata N, Ertugrul DT, Yalcin AA, Yenigun EC, Kizilca G, Okten H, Akin KO, Nazligul Y. The relationship between updated Sydney system score and LDL cholesterol levels in patients infected with Helicobacter pylori. Dig Dis Sci. 2009;54:604-607.
  57. Satoh H, Saiyo Y, Yoshioka E, Tsutsui H. Helicobacter pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb. 2010;17:1041-1048.
  58. Kim H-L, Jeon HH, Park IY, Choi JM, Kang JS, Min K-W. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korea Med Sci. 2011;26(5):654-658. https://doi.org/10.3346/jkms.2011.26.5.654
  59. Niemelä S, Kartiunen T, Korhonen H, Läärä H, Kartiunen R, Ikäheimo M, Kesäniemi YA. Could Helicobacter pylori infection increase the risk of coronary artery disease by modifying serum lipid concentration? Heart. 1996;75:573-575.
  60. Erdogan AF, Asma S, Gereklioglu C, Turan I, Abaci K. Association between Helicobacter pylori infection and low density lipoprotein cholesterol. Turkish journal of family medicine and primary care (TJFMPC). 2014;8(1):19-24. https://doi.org/10.5455/tjfmpc.41121
  61. Nam SY, Ryu KH, Park BJ, Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2014;20(2):125-132. https://doi.org/10.1111/hel.12182
  62. Mukhtar MH, Nasif WA, Babakr AT. Helicobacter pylori infection is associated with dyslipidemia and increased levels of oxidized LDL in type-2 diabetes mellitus. J Diabet Mellitus. 2016;6:185-190. https://doi.org/10.4236/jdm.2016.63020
  63. Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci. 2005;50:1228-1231.
  64. Albaker WI. Helicobacter pylori infection and its relationship to metabolic syndrome. Is it myth or fact? Saudi J Gastroenterol. 2011;17(3):165-169. https://doi.org/10.4103/1319-3767.80377
  65. Kopacova M, Bures J, Koupil I, Rejchrt S, Vorisek V, Seifert B et al. Body indices and basic vital sings in Helicobacter pylori positive and negative persons. Eur J Еpidemiol. 2007;22(1):67-75. https://doi.org/10.1007/s10654-006-9090-1
  66. Harvey R, Lane A, Murray L, Harvey I, Nair P, Donovan J. Effect of Helicobacter pylori infection on blood pressure. A community based cross sectional study. Br Med J. 2001;323:264-265.
  67. Мigneco A, Ojetti V, Specchia L, Franceschi F, Candelli M, Mettimano M, Montebelli R, Savi L, Gasbarrini G. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter. 2003;8:585-589.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies